rs549293063

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001145809.2(MYH14):​c.94C>T​(p.Arg32Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000154 in 1,548,070 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00016 ( 3 hom. )

Consequence

MYH14
NM_001145809.2 missense

Scores

1
5
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 0.690
Variant links:
Genes affected
MYH14 (HGNC:23212): (myosin heavy chain 14) This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0112657845).
BP6
Variant 19-50210459-C-T is Benign according to our data. Variant chr19-50210459-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 445916.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000118 (18/152274) while in subpopulation SAS AF= 0.00352 (17/4828). AF 95% confidence interval is 0.00224. There are 0 homozygotes in gnomad4. There are 16 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 18 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MYH14NM_001145809.2 linkuse as main transcriptc.94C>T p.Arg32Cys missense_variant 2/43 ENST00000642316.2 NP_001139281.1
MYH14NM_001077186.2 linkuse as main transcriptc.94C>T p.Arg32Cys missense_variant 2/42 NP_001070654.1
MYH14NM_024729.4 linkuse as main transcriptc.94C>T p.Arg32Cys missense_variant 2/41 NP_079005.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MYH14ENST00000642316.2 linkuse as main transcriptc.94C>T p.Arg32Cys missense_variant 2/43 NM_001145809.2 ENSP00000493594 Q7Z406-2

Frequencies

GnomAD3 genomes
AF:
0.000125
AC:
19
AN:
152162
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00373
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000301
AC:
44
AN:
146074
Hom.:
1
AF XY:
0.000400
AC XY:
32
AN XY:
80068
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00168
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000912
Gnomad OTH exome
AF:
0.000241
GnomAD4 exome
AF:
0.000158
AC:
220
AN:
1395796
Hom.:
3
Cov.:
33
AF XY:
0.000219
AC XY:
151
AN XY:
689312
show subpopulations
Gnomad4 AFR exome
AF:
0.0000327
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00214
Gnomad4 FIN exome
AF:
0.0000423
Gnomad4 NFE exome
AF:
0.0000306
Gnomad4 OTH exome
AF:
0.000225
GnomAD4 genome
AF:
0.000118
AC:
18
AN:
152274
Hom.:
0
Cov.:
32
AF XY:
0.000215
AC XY:
16
AN XY:
74460
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00352
Gnomad4 FIN
AF:
0.0000942
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000435
Hom.:
0
Bravo
AF:
0.0000453
ExAC
AF:
0.000293
AC:
31
Asia WGS
AF:
0.00231
AC:
8
AN:
3470

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenOct 01, 2023MYH14: BS1 -
Uncertain significance, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsFeb 22, 2017- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 04, 2024The c.94C>T (p.R32C) alteration is located in exon 2 (coding exon 1) of the MYH14 gene. This alteration results from a C to T substitution at nucleotide position 94, causing the arginine (R) at amino acid position 32 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
MYH14-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesAug 15, 2024This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.40
.;.;T;.;T;.;.;T
Eigen
Benign
-0.90
Eigen_PC
Benign
-0.90
FATHMM_MKL
Benign
0.039
N
LIST_S2
Benign
0.75
.;T;T;.;T;T;T;.
M_CAP
Uncertain
0.29
D
MetaRNN
Benign
0.011
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.54
T
MutationAssessor
Benign
1.6
L;L;L;L;.;L;.;L
MutationTaster
Benign
1.0
N;N;N;N
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
-1.6
.;N;N;.;.;.;.;.
REVEL
Uncertain
0.29
Sift
Pathogenic
0.0
.;D;D;.;.;.;.;.
Sift4G
Uncertain
0.0030
D;D;D;.;D;D;.;D
Polyphen
0.0030
B;B;B;B;.;B;.;B
Vest4
0.20
MutPred
0.32
Gain of catalytic residue at P31 (P = 0.0074);Gain of catalytic residue at P31 (P = 0.0074);Gain of catalytic residue at P31 (P = 0.0074);Gain of catalytic residue at P31 (P = 0.0074);Gain of catalytic residue at P31 (P = 0.0074);Gain of catalytic residue at P31 (P = 0.0074);Gain of catalytic residue at P31 (P = 0.0074);Gain of catalytic residue at P31 (P = 0.0074);
MVP
0.61
MPC
0.63
ClinPred
0.11
T
GERP RS
2.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.074
gMVP
0.54

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs549293063; hg19: chr19-50713716; API